Connie Endvick
Acute Care · Wausau, WINPI 1376087775
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $386 of the $441 with a category attached, or 87.5%. 9 manufacturers reported payments, led by Inspire Medical Systems, Inc. at 33.4% of the total. 2024 is the largest year on record at $295, more than ten times the $14 reported in 2022.
Across 17 payments — averaging $25.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Inspire Medical Systems, Inc.$147
- Boehringer Ingelheim$70
- Sanofi-aventis U.S. LLC$55
- AstraZeneca$52
- GSK$45
- Insmed, Inc.$28
- plus $44 from 3 others
What the payments were for
- Food & beverage$38688%
- Education$5512%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Inspire Medical Systems, Inc. | 4 | $147 |
| Boehringer Ingelheim | 2 | $70 |
| Sanofi-aventis U.S. LLC | 1 | $55 |
| AstraZeneca | 3 | $52 |
| GSK | 3 | $45 |
| Insmed, Inc. | 1 | $28 |
| Electromed, Inc. | 1 | $16 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
| Sanofi | 1 | $14 |
How this compares
$441 in reported general payments places this provider in the 75th percentile of 127 acute care providers in Wisconsin.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 24 | $20,318 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 15 | $11,129 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 11 | $5,242 |
| Bevespi AerosphereGlycopyrrolate/Formoterol Fum | 11 | $4,698 |
| SymbicortBudesonide/Formoterol Fumarate | 13 | $4,476 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 14 | $2,088 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 52 | $1,243 |
| Fluticasone Propionate | 14 | $481 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta | $45 | $20,31824 claims |
| AstraZenecaBreztri Aerosphere, Bevespi Aerosphere, Symbicort | $52 | $20,30439 claims |
| Boehringer IngelheimStiolto Respimat | $70 | $5,24211 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 127 acute care providers in Wisconsin.
Other acute care in Wausau
- Deborah SauerWausau$4K
- Joshua GraberWausau$576
- Jennifer VernaWausau$377
- Beth WrightWausau$320
- Kelsey CramerMilwaukee$5K
- Billie LawlerMount Pleasant$5K
- Elizabeth LaufenbergMilwaukee$5K
- Joel SchaeveBrookfield$4K
- Avery LebowitzMenasha$4K
- Evgeniya KhenOconomowoc$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.